IL9 and neoplasm: Specifically, Tc9 cell-derived IL-9 can activate STAT3 to increase fatty acid oxidation and mitochondrial activity, which imparts Tc9 cells with reduced lipid peroxidation and the resistance to tumor or ROS-induced ferroptosis.